The rise of raloxifene and the fall of invasive breast cancer

J Natl Cancer Inst. 2008 Jun 18;100(12):831-3. doi: 10.1093/jnci/djn177. Epub 2008 Jun 10.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aged
  • Animals
  • Anticholesteremic Agents / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Bone Density / drug effects
  • Bone Density Conservation Agents / therapeutic use*
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / pathology
  • Breast Neoplasms / prevention & control*
  • Coronary Disease / prevention & control
  • Evidence-Based Medicine
  • Female
  • Humans
  • Incidence
  • Middle Aged
  • Neoplasm Invasiveness
  • Osteoporosis, Postmenopausal / prevention & control*
  • Raloxifene Hydrochloride / therapeutic use*
  • Selective Estrogen Receptor Modulators / therapeutic use*

Substances

  • Anticholesteremic Agents
  • Antineoplastic Agents, Hormonal
  • Bone Density Conservation Agents
  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride